Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:342

Pharmaceuticals Market Research

Items 11 to 20 of 925 total
  1. 
FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    Date of report : Dec 4, 2011
    $500.00

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade Summary GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provides key update on the approval of Yervoy as the first targeted therapy for melanoma. Sc...  Learn More
  2. 
FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade

    Date of report : Dec 4, 2011
    $500.00

    FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade Summary GlobalData’s report, “FDA Approves Yervoy (Ipilimumab), First Targeted Melanoma Therapy for Over a Decade” provides key update on the approval of Yervoy as the first targeted therapy for melanoma. Sc...  Learn More
  3. China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis

    China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis

    Date of report : Nov 6, 2011
    $200.00

    The Chinese pharmaceuticals market is forecast to become the world's firth largest by 2010 - and the largest by 2050. There are still greater market access following China's entry into the World Trade Organization (WTO), multinational investors continue to face a range of obstacles, many of which st...  Learn More
  4. Looking at Chiral Technologies

    Looking at Chiral Technologies

    Date of report : Nov 6, 2011
    $175.00

    The advancements in molecular research and continued untiring efforts of the research industry to develop better more precisely applicable Pharmaceuticals as well as agro compounds would have not been possible without the advent of Chiral technologies and their applications. The usage of chiral mol...  Learn More
  5. Canada’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    Canada’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    Date of report : Nov 6, 2011
    $175.00

    The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the quality of life for the world’s citize...  Learn More
  6. Looking at the Cancer Therapy Market

    Looking at the Cancer Therapy Market

    Date of report : Nov 6, 2011
    $200.00

    Cancer is a disease characterized by a population of cells that grow and divide without respect to normal limits, invade and destroy adjacent tissues, and may spread to distant anatomic sites through a process called metastasis. These life-threatening, malignant properties of cancers differentiate t...  Learn More
  7. Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    Japan’s Biotechnology Industry - Porter’s Five Forces Strategy Analysis

    Date of report : Nov 6, 2011
    $175.00

    The rapidly emerging biotechnology industry is a critical element of national power. Advances in biotechnology are resulting in novel biomedical and pharmaceutical products and processes that are relieving human suffering, improving health, and increasing the quality of life for the world’s citize...  Learn More
  8. US Pharmaceutical Industry – PEST Framework Analysis

    US Pharmaceutical Industry – PEST Framework Analysis

    Date of report : Nov 6, 2011
    $175.00

    Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition. Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborat...  Learn More
  9. Looking at Offshoring in the Pharmaceutical Industry

    Looking at Offshoring in the Pharmaceutical Industry

    Date of report : Nov 6, 2011
    $300.00

    The organic spread of pharmaceutical industry worldwide has necessitated taking steps beyond only export of drug lifecycles across time based zones to development in those countries itself in order to capitalize on the opportunities present in these countries whether in terms of knowledge resources ...  Learn More
  10. Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

    Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis

    Date of report : Nov 6, 2011
    $175.00

    Pharmaceutical is one of the most intense “Knowledge Driven” industries, which is continually in a state of dynamic transition.Diversities in life forms and diseases pose stiff challenge to the design of specific and targeted solutions. The process of “drug discovery/invention” is elaborate...  Learn More
Items 11 to 20 of 925 total
LiveZilla Live Help